Endogenous catabolism is the major source of toxic metabolites in isovaleric acidemia
- 1 January 1987
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 110 (1), 56-60
- https://doi.org/10.1016/s0022-3476(87)80288-3
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- L-carnitine therapy in isovaleric acidemia.Journal of Clinical Investigation, 1984
- Stable isotope dilution analysis of 3‐hydroxyisovaleric acid in amniotic fluid: Contribution to the prenatal diagnosis of inherited disorders of leucine catabolismJournal of Inherited Metabolic Disease, 1983
- Isovaleric Acidemia: Use of Glycine Therapy in NeonatesNew England Journal of Medicine, 1978
- Glycine therapy in isovaleric acidemiaThe Journal of Pediatrics, 1978
- Therapeutic Effects of Glycine in Isovaleric AcidemiaPediatric Research, 1976
- Identification of β-hydroxyisovaleric acid in the urine of a patient with isovaleric acidemiaBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1968
- Propionylcarnitine physiological variations in vivoBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1968
- The Isolation and Identification of N-Isovalerylglycine from Urine of Patients with Isovaleric AcidemiaJournal of Biological Chemistry, 1967
- Intestinal Absorption of Essential Amino Acids in ManGastroenterology, 1967
- Isovaleric acidemia: a new genetic defect of leucine metabolism.Proceedings of the National Academy of Sciences, 1966